Niagen Bioscience, Inc. NAGE
2.56 USD +0.20 (+8.47%)
Nov 4, 2026, 1:47 PM EST
2.40 Day range 2.59
2.31 52-week range 7.95
- YTD
- -59.75%
- 1 year
- -63.17%
Analyst view
Price target (mean) 14.90 +482.0% upside
Now 2.56
- Target (low)
- 9.60
- Target (mean)
- 14.90
- Target (high)
- 23.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00667 | -0.01 – 0.02 | 0.00 | 0.0% | 28.36M | +24.7% | 3 |
| Next quarter | 0.01333 | 0.01 – 0.02 | 0.02 | -33.4% | 30.71M | +20.0% | 3 |
| Current year | 0.10667 | 0.08 – 0.14 | 0.0495 | +115.5% | 123.37M | +23.9% | 3 |
| Next year | 0.20333 | 0.17 – 0.24 | 0.10667 | +90.6% | 148.23M | +20.2% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 10, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 6, 2025 | Roth Capital | Maintained | Buy | Buy |
| May 27, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Apr 8, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 31, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 17, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 10, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 5, 2025 | Ladenburg Thalmann | Maintained | Buy | Buy |
| Nov 6, 2024 | Roth MKM | Maintained | Buy | Buy |
| Nov 4, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |